Legal & General Group
CDLX icon

Legal & General Group’s Cardlytics CDLX Stock Holding History

Legal & General Group’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-464
Closed -$8.45K – 3439
2025
Q1 		$8.45K Hold
464
– – ﹤0.01% 3210
2024
Q4 		$17.2K Hold
464
– – ﹤0.01% 3079
2024
Q3 		$14.9K Hold
464
– – ﹤0.01% 3161
2024
Q2 		$38.1K Buy
464
+153
+49% +$16.5K ﹤0.01% 2832
2024
Q1 		$45K Hold
311
– – ﹤0.01% 2788
2023
Q4 		$28.6K Buy
311
+30
+11% +$3.05K ﹤0.01% 2907
2023
Q3 		$46.4K Sell
281
-43
-13% -$5.59K ﹤0.01% 2873
2023
Q2 		$20.5K Buy
324
+38
+13% +$2.3K ﹤0.01% 3105
2023
Q1 		$9.69K Sell
286
-2,706
-90% -$141K ﹤0.01% 3211
2022
Q4 		$173K Buy
2,992
+30
+1% +$1.85K ﹤0.01% 2675
2022
Q3 		$279K Buy
2,962
+60
+2% +$8.54K ﹤0.01% 2496
2022
Q2 		$648K Sell
2,902
-87
-3% -$29.1K ﹤0.01% 2290
2022
Q1 		$1.64M Buy
2,989
+31
+1% +$18.7K ﹤0.01% 2063
2021
Q4 		$1.96M Buy
2,958
+6
+0.2% +$4.59K ﹤0.01% 2041
2021
Q3 		$2.48M Buy
2,952
+829
+39% +$841K ﹤0.01% 1923
2021
Q2 		$2.69M Buy
2,123
+118
+6% +$133K ﹤0.01% 1839
2021
Q1 		$2.2M Buy
2,005
+1,402
+233% +$1.85M ﹤0.01% 1943
2020
Q4 		$861K Sell
603
-28
-4% -$29.9K ﹤0.01% 2153
2020
Q3 		$445K Sell
631
-73
-10% -$53.1K ﹤0.01% 2226
2020
Q2 		$493K Buy
704
+401
+132% +$232K ﹤0.01% 2172
2020
Q1 		$106K Sell
303
-65
-18% -$46K ﹤0.01% 2392
2019
Q4 		$231K Buy
368
+142
+63% +$69.4K ﹤0.01% 2365
2019
Q3 		$76K Hold
226
– – ﹤0.01% 2609
2019
Q2 		$59K Buy
226
+136
+151% +$27.2K ﹤0.01% 2704
2019
Q1 		$15K Hold
90
– – ﹤0.01% 3169
2018
Q4 		$10K Hold
90
– – ﹤0.01% 3271
2018
Q3 		$23K Hold
90
– – ﹤0.01% 3146
2018
Q2 		$20K Hold
90
– – ﹤0.01% 3186
2018
Q1 		$13K Buy
+90
New +$15.2K ﹤0.01% 3183

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Legal & General Group's CDLX Position: Q2 2025 in Review

Legal & General Group sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 464 shares — an estimated $8.45K sold.

Legal & General Group first reported a position in CDLX in Q1 2018 and held it in 29 quarters. The position peaked at $2.69M in Q2 2021. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Legal & General Group reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 464 Cardlytics shares in Q2 2025, an estimated $8.45K.
  • Legal & General Group first reported a position in Cardlytics in Q1 2018 and held it in 29 quarters.
  • Legal & General Group's Cardlytics position peaked at $2.69M in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.